Our focus areas
Our research encompasses four focus areas, or areas of strength, including cancer, inflammation, infectious disease and wounds, neurodegenerative disorders and vascular and metabolic disorders.
We’re researching interventions for age-associated cancers, focusing on how the immune system influences cancer risk and disease progression.
Inflammation, infectious disease and wounds
We are developing ways to stop the decline in immune system function with ageing, using the immune system to treat arthritis and adult cancers.
We are exploring new approaches for preventing and treating Alzheimer’s disease, where we’re hoping to slow cognitive decline significantly.
Vascular and metabolic disorders
We are identifying new treatments for blood vessel disorders and investigating blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders, energy disorders, liver disorders and infectious diseases.
CHIRI in the news
Ground-breaking new Curtin-led research has discovered a likely cause of Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities.
Curtin University researchers have been awarded more than $1.1million from MSWA to conduct vital neurological research, focussing on major outcomes for people living with MS and Alzheimer’s disease.
Curtin researchers awarded almost $500,000 in Federal Government funding to help improve care for people with traumatic brain injury, including those in rural, remote and Aboriginal communities.
Curtin researchers have discovered a new way to improve the absorption rate of medicinal cannabis, which could potentially treat neurological disorders such as Alzheimer’s disease.
Connect with us to explore the many ways you can support us and our researchers to make a difference.